血小板功能评价预测冠脉介入——臆度还是希望?

Predicting Outcomes after Coronary Intervention by Assessment of Platelet Function

抗血小板治疗与经皮冠脉介入治疗患者临床结果密切相关,药物剂量和作用时间直接影响患者预后,而患者对血小板治疗的反应多变,能否制定出个体化的最佳治疗方案,或许血小板功能的研究会给我们带来希望。

Anti-platelet therapy has close relationship with the clinical outcomes of patients after percutaneous coronary intervention. The dosage and action time of drugs affect the prognosis of patients directly,and the patients＇ action to platelet therapy varies. So the study of platelet function assessment may take hope for providing the basis of individual optimal strategy.